MobiHealth News September 11, 2023

Control costs, increase care access and elevate patient experiences.

CAR T-cell therapy is used to treat patients with blood cancers such as multiple myeloma. Since it can cause serious side effects, patients are usually hospitalized and monitored for up to two weeks after therapy. With treatments generally only offered at large cancer centers, they can be difficult to access for many patients. Join Dr. Sridevi Rajeeve, Myeloma and Cell Therapy Oncologist at Memorial Sloan Kettering Cancer...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Conferences / Podcast, Digital Health, Home, Patient / Consumer, Provider, Technology, Trends
Related Articles:
In search of a long-term approach to telehealth and hospital-at-home
Atrium Health Launches Nation’s First Pediatric Hospital-At-Home Model
Home-Based Pediatric Care A Leap For Patients, A Struggle For Providers
Atrium Health launches pediatric hospital-at-home program
DispatchHealth and Medically Home merge, Updates on Marathon Health, 23andMe’s Bankruptcy and more Healthcare news this week

Share This Article